Thyroid disease

Cardiovascular morbidity and mortality in patients in Wales, UK with resistance to thyroid hormone β (RTHβ): a linked-record cohort study

Lancet Diabetes EndocrinolPublished Retrospective cohort study

Authors' conclusion

We have documented reduced survival and increased cardiovascular morbidity in a cohort of patients with RTHβ for the first time. These outcomes might be driven by lifelong cardiac exposure to thyroid hormone excess; and effective therapies, targeting hormone resistant pathways, could potentially curtail this risk.

Study context

Population
Genetically confirmed patients with resistance to thyroid hormone β (RTHβ) followed in UK endocrine clinics, diagnosed Jan 1, 1997–Dec 31, 2019; Welsh Secure Anonymised Information Linkage (SAIL) Databankmatched cohort
Participants
61 vs 2,750
Exposure
Patients with RTHβ vs matched population controls
  • RTHβn = 61
  • Controlsn = 2,750reference
Outcome
All-cause mortality and cardiovascular events
Methodological detailslinked-record, age-matched and sex-matched population controls, Kaplan-Meier and Cox regression models
  • Linked-record
  • Age-matched and sex-matched population controls
  • Kaplan-Meier and Cox regression models

Main finding

As reported in the abstract

RTHβ vs ControlsHazard ratio (95% CI)
All-cause mortality
2.84(1.59–5.08)
HF
6.35(2.26–17.86)
MACE (CV death, acute MI, HF or stroke)
3.49(2.04–5.99)
AF
10.56 (95% CI 4.72–23.63)

Observational data: associations, not effects.

Further findings

Age at first occurrence of any adverse event · earlier in RTHβ

difference 11

FT4 at diagnosis and mortality or major adverse cardiovascular events (MACE)

Positive association between FT4 at diagnosis and mortality or MACE (cubic spline); FT4 ≥30 pmol/L conferred increased risk

Treatment and thyroid hormone excess

Antithyroid drugs, surgery or RAI ablation, or thyroxine did not control thyroid hormone excess vs no intervention

Original publication

Cardiovascular morbidity and mortality in patients in Wales, UK with resistance to thyroid hormone β (RTHβ): a linked-record cohort study. Lancet Diabetes Endocrinol. Published 17 July 2023. doi:10.1016/s2213-8587(23)00155-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.